|
|
|
Insider
Information: |
Harrison Seth Loring |
Relationship: |
Director |
City: |
Sydney, Nsw |
State: |
C3 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
10,594,431 |
|
Indirect Shares
|
25,221,855 |
|
|
Direct
Value |
$5,050,848 |
|
|
Indirect Value
|
$20,413,164 |
|
|
Total
Shares |
35,816,286 |
|
|
Total
Value |
$25,464,011 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
HeartWare International Inc |
HTWR |
Director |
2016-08-23 |
0 |
2016-08-23 |
0 |
Premium* |
|
Titan Pharmaceuticals Inc |
TTNP |
10% Owner |
2013-11-25 |
9,650,000 |
|
0 |
Premium* |
|
Eledon Pharmaceuticals Ord Shs |
ELDN |
Director, 10% Owner |
2014-09-22 |
212,694 |
2014-09-22 |
7,912,079 |
Premium* |
|
Avalo Therapeutics, Inc |
AVTX |
Director, 10% Owner |
2015-10-20 |
595,436 |
2015-10-20 |
0 |
Premium* |
|
Stoke Therapeutics, Inc. |
STOK |
Director, 10% Owner |
2019-06-21 |
0 |
2020-11-24 |
17,161,713 |
Premium* |
|
Akero Therapeutics, Inc. |
AKRO |
Director |
2022-11-30 |
136,301 |
2022-11-30 |
148,063 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HTWR |
HeartWare International I... |
Director |
|
2012-07-16 |
4 |
AS |
$90.21 |
$1,575,067 |
D/D |
(17,460) |
54,951 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2012-07-13 |
4 |
AS |
$90.00 |
$745,110 |
D/D |
(8,279) |
72,411 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2013-03-18 |
4 |
A |
$0.00 |
$0 |
I/I |
39,625 |
79,250 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2012-07-12 |
4 |
AS |
$90.00 |
$15,750 |
D/D |
(175) |
80,690 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2012-07-03 |
4 |
AS |
$90.00 |
$42,570 |
D/D |
(473) |
80,865 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2012-07-02 |
4 |
AS |
$90.00 |
$56,700 |
D/D |
(630) |
81,338 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2012-04-26 |
4 |
AS |
$77.19 |
$2,087,486 |
D/D |
(27,017) |
81,385 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2012-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
333 |
81,718 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2012-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
250 |
81,968 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2012-03-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
18,328 |
108,402 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
126,396 |
126,730 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2012-03-01 |
4 |
A |
$0.00 |
$0 |
I/I |
130,574 |
130,574 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2014-01-06 |
4 |
AS |
$99.29 |
$785,285 |
D/D |
(7,909) |
132,393 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2016-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
500 |
132,393 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2014-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
500 |
132,893 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2014-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
250 |
133,143 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2016-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
133,393 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2015-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,500 |
134,643 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2015-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
250 |
134,893 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Director |
|
2022-11-30 |
4 |
S |
$46.44 |
$521,067 |
D/D |
(11,101) |
136,301 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2013-07-01 |
4 |
S |
$95.29 |
$1,253,734 |
D/D |
(13,118) |
140,302 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Director |
|
2022-10-28 |
4 |
S |
$40.28 |
$852,091 |
D/D |
(21,138) |
147,402 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Director |
|
2022-11-30 |
4 |
S |
$46.44 |
$564,673 |
I/I |
(12,030) |
148,063 |
0 |
- |
|
HTWR |
HeartWare International I... |
Director |
|
2013-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
105,136 |
153,420 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Director |
|
2022-10-28 |
4 |
S |
$40.28 |
$925,738 |
I/I |
(22,965) |
160,093 |
0 |
- |
|
89 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|